Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer
- 1 October 2013
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 131 (1), 21-26
- https://doi.org/10.1016/j.ygyno.2013.07.100
Abstract
No abstract availableKeywords
Funding Information
- Genentech
- Genentech
- National Cancer Institute
This publication has 6 references indexed in Scilit:
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian CancerThe New England Journal of Medicine, 2011
- Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysisEuropean Journal of Cancer, 2011
- 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus ConferenceInternational Journal of Gynecologic Cancer, 2011
- Lapatinib plus Capecitabine for HER2-Positive Advanced Breast CancerThe New England Journal of Medicine, 2006
- Sorafenib for the Treatment of Advanced Renal Cell CarcinomaClinical Cancer Research, 2006
- Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trialThe Lancet, 2006